CorMedix
CRMD
#7253
Rank
A$0.87 B
Marketcap
A$11.18
Share price
1.03%
Change (1 day)
-38.17%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2026 (TTM): A$0.27 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.40 Billion. In 2025 the company made an earning of A$0.21 Billion, an increase over its 2024 earnings that were of -A$27.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.27 B28.78%
2025 A$0.21 B-876.29%
2024 -A$27.53 Million-58.3%
2023 -A$66 Million53%
2022 -A$43.14 Million2.81%
2021 -A$41.96 Million8.32%
2020 -A$38.74 Million26.53%
2019 -A$30.62 Million-19.89%
2018 -A$38.22 Million-18.72%
2017 -A$47.02 Million34.56%
2016 -A$34.94 Million34.88%
2015 -A$25.91 Million-11.08%
2014 -A$29.13 Million124.69%
2013 -A$12.97 Million144.91%
2012 -A$5.3 Million-48.41%
2011 -A$10.27 Million-33.29%
2010 -A$15.39 Million78.42%
2009 -A$8.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.34 B 789.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$19.13 M-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$84.17 M-68.06%๐Ÿ‡บ๐Ÿ‡ธ USA